Vaccines for Immune-Mediated Diseases

Patients with safe interceded incendiary ailments (IMID, for instance, RA, IBD or skin problem, square measure at increased danger of contamination, partially in light-weight of the malady itself, but for the foremost half in light-weight of treatment with immune modulatory or immunological disorder medications. in spite of their raised hazard for immunisation preventable upset, the immunisation scope in IMID patients is shockingly low.

    Related Conference of Vaccines for Immune-Mediated Diseases

    May 22-23, 2023

    41st Euro Global Summit and Expo on Vaccines & Vaccination

    Berlin, Germany
    July 31-01, 2023

    35th International Conference on Vaccines and Immunization

    Vancouver, Canada
    August 21-22, 2023

    6th International Conference on Vaccines and Immunology

    Paris, France
    October 18-19, 2023

    43rd Global Summit and Expo on Vaccines & Immunology

    Vienna, Austria
    November 04-05, 2023

    35th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 06-07, 2023

    5th World Congress on Vaccine and Immunology

    Tokyo, Japan
    February 08-09, 2024

    International Conference on Vaccine Research

    Madrid, Spain
    March 20-21, 2024

    7th International Conference on Vaccines, Immunology and Clinical Trials

    Amsterdam, Netherlands

    Vaccines for Immune-Mediated Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in